* Thorne Healthtech Inc THRN.OQ reported quarterly adjusted
earnings of 1 cents per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 3 cents per share.
* Revenue was $48.01 million; analysts expected $45.35
million.
* Thorne Healthtech Inc's reported EPS for the quarter was 1
cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Thorne Healthtech Inc shares had risen by 11.0% this quarter.
* The company reported quarterly net income of $475.71 thousand.
* Wall Street's median 12-month price target for Thorne
Healthtech Inc is $11.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated November 10 at 02:32 p.m.
All figures in US dollars unless otherwise stated